SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-012639
Filing Date
2022-07-12
Accepted
2022-07-12 16:05:50
Documents
15
Period of Report
2022-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K reta-20220711.htm   iXBRL 8-K 69755
2 EX-10.1 reta-ex10_1.htm EX-10.1 198170
3 EX-99.1 reta-ex99_1.htm EX-99.1 17853
4 GRAPHIC img141630853_0.jpg GRAPHIC 5638
  Complete submission text file 0000950170-22-012639.txt   448416

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reta-20220711_lab.xml EX-101.LAB 13186
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reta-20220711_pre.xml EX-101.PRE 10502
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reta-20220711.xsd EX-101.SCH 2461
9 EXTRACTED XBRL INSTANCE DOCUMENT reta-20220711_htm.xml XML 4530
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 221079257
SIC: 2834 Pharmaceutical Preparations